C14orf44 Activators encompass a range of chemical compounds that, through their action on various signaling pathways, may indirectly enhance the functional activity of C14orf44. For instance, Forskolin and IBMX both act to elevate intracellular cAMP levels, which in turn can activate protein kinase A (PKA). PKA has a broad range of substrates, and if C14orf44 is associated with cAMP response element-binding protein (CREB) regulated pathways, its activity could be upregulated. Similarly, Lithium chloride's inhibition of GSK-3β and Retinoic acid's modulation of gene expression via retinoic acid receptors could enhance C14orf44 if it is a downstream target in these signaling cascades. Polyphenolic compounds such as Epigallocatechin gallate (EGCG) and Curcumin, as well as the stilbenoid Resveratrol, with their multi-targeted effects on cellular signaling, could create an environment conducive to the augmentation of C14orf44 activity, depending on the protein's involvement in affected pathways.
Additionally, compounds like Spermidine and Rapamycin that induce autophagy could influence C14orf44 activity if it plays a role in this cellular process. Sodium butyrate's role in increasing chromatin accessibility may also lead to an upregulation of C14orf44, assuming that its expression is regulated by histone acetylation. Activation of protein kinase C (PKC) by PMA, and modulation of PI3K activity by LY294002, could similarly shiftthe signaling equilibrium in a manner that favors C14orf44 activation, contingent on its participation in these signaling networks. The diverse array of these activators illustrates the complex interplay between cellular signaling mechanisms and the potential indirect enhancement of C14orf44 activity within these contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP and activation of PKA, potentially influencing pathways that indirectly enhance C14orf44 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that can modulate various signaling pathways, potentially altering the cellular environment in a way that upregulates C14orf44 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, which could lead to activation of downstream proteins and might indirectly increase C14orf44 activity if C14orf44 is involved in pathways regulated by GSK-3β. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression through retinoic acid receptors. If C14orf44 activity is linked to these pathways, retinoic acid could lead to its functional enhancement. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
May induce autophagy, which could influence C14orf44 activity if C14orf44 is implicated in autophagy-related pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which could enhance C14orf44 activity if C14orf44 is regulated by PKC-dependent signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates multiple signaling pathways and could upregulate C14orf44 activity if C14orf44 is part of those pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that could increase chromatin accessibility and potentially enhance C14orf44 activity if it is regulated by histone acetylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which could indirectly enhance C14orf44 activity if C14orf44 is involved in SIRT1-regulated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could shift cellular signaling dynamics in a way that could lead to enhanced activity of C14orf44 if PI3K signaling affects C14orf44 activity. | ||||||